why choose us

First received: November 4, 2022

Clinical Trial: Felodipine Controlled Release Tablets and Felodipine Sustained Release Tablets in Healthy Subjects Under Fasting State Comparative Pharmacokinetic Study

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Hypertension

Study Type: Interventional


Official Title: Felodipine Controlled Release Tablets and Felodipine Sustained Release Tablets in Healthy Subjects Under Fasting State: Single Dose, Randomized, Open, 2-treatment?2-period?Crossover Comparative Pharma

Brief Summary: Felodipine Controlled Release Tablets and Felodipine Modified-release Tablets in Healthy Subjects Under Fasting State: Single Dose, Randomized, Open, 2-treatment?2-period?Crossover Comparative Pharmacokinetic StudyMain research objectives:Felodipine Controlled Release Tablets(strength: 5 mg) developed by Overseas Pharmaceuticals, Ltd., and Felodipine Modified-release Tablets (strength: 5 mg) produced by AstraZeneca AB., trade name: The pharmacokinetic parameters of the test preparation and the reference…

Read more